PHARMACIE BLANCHARD : revenue, balance sheet and financial ratios

PHARMACIE BLANCHARD is a French company founded 26 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in LISIEUX (14100), this company of category PME shows in 2017 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BLANCHARD (SIREN 429923303)
Indicator 2018 2017 2016
Revenue N/C 1 184 598 € 1 210 572 €
Net income 9 979 € 257 406 € -17 234 €
EBITDA N/C 54 423 € 71 549 €
Net margin N/C 21.7% -1.4%

Revenue and income statement

In 2018, PHARMACIE BLANCHARD generates positive net income of 10 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2018) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

9 979 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 48%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2018) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

48.385%

Financial autonomy (2018) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

55.733%

Asset age ratio (2018) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.2%

Solvency indicators evolution
PHARMACIE BLANCHARD

Sector positioning

Debt ratio
48.38 2018
2016
2017
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Good -12 pts over 3 years

In 2018, the debt ratio of PHARMACIE BLANCHARD (48.38) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
55.73% 2018
2016
2017
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Good +28 pts over 3 years

In 2018, the financial autonomy of PHARMACIE BLANCHARD (55.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.87 years 2017
2016
2017
Q1: 2.26 years
Med: 5.89 years
Q3: 10.41 years
Excellent

In 2017, the repayment capacity of PHARMACIE BLANCHARD (0.87) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 60.29. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2018) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

60.292

Liquidity indicators evolution
PHARMACIE BLANCHARD

Sector positioning

Liquidity ratio
60.29 2018
2016
2017
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Watch -8 pts over 3 years

In 2018, the liquidity ratio of PHARMACIE BLANCHARD (60.29) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
20.56x 2017
2016
2017
Q1: 2.82x
Med: 8.19x
Q3: 15.34x
Excellent

In 2017, the interest coverage of PHARMACIE BLANCHARD (20.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2018) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2018) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2018) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2018) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE BLANCHARD

Positioning of PHARMACIE BLANCHARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 177 transactions of similar company sales in 2018, the value of PHARMACIE BLANCHARD is estimated at 125 644 € (range 93 644€ - 206 655€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2018
177 transactions
93k€ 125k€ 206k€
125 644 € Range: 93 644€ - 206 655€
NAF 5 année 2018

Valuation method used

Net Income Multiple
9 979 € × 12.6x = 125 645 €
Range: 93 644€ - 206 656€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BLANCHARD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE BLANCHARD

What is the revenue of PHARMACIE BLANCHARD ?

The revenue of PHARMACIE BLANCHARD in 2017 is 1.2 M€.

Is PHARMACIE BLANCHARD profitable?

Yes, PHARMACIE BLANCHARD generated a net profit of 10 k€ in 2018.

Where is the headquarters of PHARMACIE BLANCHARD ?

The headquarters of PHARMACIE BLANCHARD is located in LISIEUX (14100), in the department Calvados.

Where to find the tax return of PHARMACIE BLANCHARD ?

The tax return of PHARMACIE BLANCHARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BLANCHARD operate?

PHARMACIE BLANCHARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.